The Clorox Company (NYSE:CLX) dbAccess Global Consumer Conference June 5, 2024 3:15 AM ET Company Participants Linda Rendle - CEO Kevin Jacobsen - CFO Conference Call Participants Stephen Powers - Deutsche Bank Stephen Powers All right. Good morning, everybody. Welcome back. I'm Steve Powers. I'm the Head of Deutsche Bank's US Consumer Packaged Goods franchise. And I'm thrilled to welcome back The Clorox Company to our conference. With us today are Chief Executive Officer, Linda Rendall -- sorry, Rendle. An ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) The 44th Annual William Blair Growth Stock Conference June 4, 2024 5:00 PM ET Company Participants Reshma Kewalramani - Chief Executive Officer Conference Call Participants Myles Minter - William Blair Sami Corwin - William Blair Myles Minter All right, thank you very much. Welcome back to the William Blair Growth Stock Conference, the 44th Edition, as I understand it. My name is Myles Minter. I'm a Senior Biotech analyst here at the firm. I'm joined next to ...

UiPath Inc. (NYSE:PATH) William Blair 44th Annual Growth Stock Conference June 6, 2024 10:20 AM ET Company Participants Ashim Gupta - Chief Financial Officer Conference Call Participants Jake Roberge - William Blair Jake Roberge Hi. Well, thanks everyone for joining in person in the room and those that are joining virtually over the webcast. Just to kick things off, my name is Jake Roberge. I'm the Research Analyst here at William Blair that covers UiPath. And for a full list of our research disclosures, p ...

Colgate-Palmolive Company (NYSE:CL) 21st Annual dbAccess Global Consumer Conference Call June 5, 2024 5:15 AM ET Company Participants Noel Wallace - Chairman, President & Chief Executive Officer Unidentified Analyst All right. So thanks, everybody. Welcome back. For our next session, I am thrilled to welcome back to the conference the Colgate-Palmolive Company. With us today are Chairman, President and Chief Executive Officer, Noel Wallace. And also, I'm sure many of you have seen around the conference, Chi ...

Thank you for standing by and welcome to the Meituan First Quarter 2024 Earnings Conference Call. All participants are in a listen-only mode. There will be a presentation followed by a question and answer session. If you wish to ask a question, you will need to press the star key followed by the number one on your telephone keypad. I would now like to hand the conference over to Scarlet Xu, VP and Head of Capital Markets. Please go ahead. Thank you, Operator. Good evening and good morning, everyone. Welcome ...

Dynatrace, Inc. (NYSE:DT) William Blair Growth Stock Conference Call June 4, 2024 5:40 PM ET Company Participants Rick McConnell - Chief Executive Officer Conference Call Participants Jake Roberge - William Blair & Company Jake Roberge [Call Starts Abruptly] coming, everyone today. Just to kick things off. My name is Jake Roberge. I'm the research analyst at William Blair that covers Dynatrace. And just for a full list of research disclosures, please visit our website at williamblair.com. But with that, I'd ...

Microsoft Corporation (NASDAQ:MSFT) BofA Securities 2024 Global Technology Conference Call June 6, 2024 1:00 PM ET Company Participants Ryan Roslansky - Chief Executive Officer, LinkedIn Unidentified Analyst We are fortunate to have Ryan Roslansky here, CEO of LinkedIn. Ryan, thank you for joining us. Ryan Roslansky I feel like I should stand up. Unidentified Analyst Yeah. Ryan Roslansky Sorry. Unidentified Analyst Absolutely. Thanks for coming to the conference. We're looking forward to the discussion here ...

Moderna, Inc. (NASDAQ:MRNA) Jefferies 2024 Global Healthcare Conference June 6, 2024 10:00 AM ET Company Participants Jamey Mock - CFO Conference Call Participants Michael Yee - Jefferies Michael Yee [Starts Abruptly] of Moderna, Jamey Mock, up here with us. Jamey, it's great to be here. Last I checked, you have a second product that is going to be generating revenue. So, that's very exciting. We'll talk about that, in RSV. You just got back from ASCO, a long week at ASCO talking about the pipeline and with ...

Key Points Industry/Company - **Company**: Toronto-Dominion Bank (NYSE: TD) - **Event**: TD Cowen's 8th Annual Future of the Consumer Conference - **Date**: June 6, 2024 Core Points and Arguments - **Revenue Growth**: TD Securities has seen significant revenue growth over the past 10 years, with a 50% increase in revenue to nearly $4.8 billion in 2022 and $3.7 billion in the first six months of the fiscal year [4]. - **Acquisition of TD Cowen**: The acquisition of TD Cowen has strengthened TD Securities' platform, adding US equities capabilities and a research platform [5]. - **Diversification**: TD Securities has diversified its business model to serve clients in various geographies and products, leading to a more resilient revenue stream [10]. - **Market Momentum**: The financial markets have shown momentum since last year, particularly in technology, healthcare, and energy sectors [15]. - **Integration**: The integration of TD Securities and TD Cowen is largely complete, with leadership and people aspects fully integrated and technical aspects on track to be completed by December [26]. - **AML Investigation**: TD Securities is currently undergoing an AML investigation, but it is expected to continue growing and expanding its market share [30]. - **Balance Sheet**: TD Securities' balance sheet has been instrumental in enhancing revenue and deepening relationships with clients [34]. Other Important Points - **Research Focus**: TD Securities' research philosophy focuses on innovation, thematic research, and company-specific research [6]. - **Competitive Advantages**: TD Securities has strong balance sheet and research capabilities, which are key competitive advantages [6]. - **US-Canada Differential**: There is a significant difference in the macroeconomic environment between the US and Canada, which presents opportunities for TD Securities to provide macro research and help clients navigate cross-border flows [11]. - **Capital Allocation and Financing**: TD Securities is well-positioned to assist clients with capital allocation and financing strategies, particularly in cross-border operations [11]. - **Growth Opportunities**: TD Securities sees significant growth opportunities in debt capital markets, cash equities, equity capital markets, syndicated and leveraged finance, and investment banking [31]. - **Transaction Banking and Cash Management**: TD Securities has a strong deposit and cash management platform, which presents opportunities for growth in the United States [38].

Viatris Inc. (NASDAQ:VTRS) Jefferies 2024 Global Healthcare Conference Call June 6, 2024 8:00 AM ET Company Participants Scott Smith - Chief Executive Officer Doretta Mistras - Chief Financial Officer Philippe Martin - Chief R&D Officer Conference Call Participants Glen Santangelo - Jefferies Glen Santangelo All right. Well, good morning, everybody. Thank you for joining this early. We're excited to get Day 3 going to the Jefferies Healthcare Conference. For our next presentation, we're excited to have Viat ...